Parthenon Therapeutics
Incendia Therapeutics | Breaking Barriers to Better Cancer Treatment
Boston, United States · Founded 2019 · $65.0M raised
- Headquarters
- Boston, Massachusetts
- Employees
- 11–50
- Founded
- 2019
- Business Model
- B2B
- Website
- incendiatx.com
- Total Funding
- $65.0M
- Last Round
- $65.0M Series ANov 2021
- Rounds
- 1
About
Precision oncology biotech developing novel therapies that reprogram the tumor microenvironment to fight cancer.
Summary
Parthenon Therapeutics is a Biotech company based in Boston, United States, founded in 2019. It has raised $65.0M in total across 1 round, most recently a $65.0M Series A round in Nov 2021. Investors include Northpond Ventures, Pfizer Ventures and Taiho Ventures.
Tech & App Stack
4 technologies & apps tracked
Create a free account to track companies, build lists, and unlock premium data like the full tech & app stack.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Nov 2021
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Specialty pharmaceutical company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...